Next |
home / stock / amph / amph message board
Subject | By | Source | When |
---|---|---|---|
AMPHASTAR: NEW FDA APPROVAL OPENS A FLOODGATE OF OPPORTUNITIES$AMPHExcited to share an article about | | mwn | 03/12/2023 9:32:53 PM |
I've bought some $AMPH at $31. Great products | Gentlemen Prefer Bonds | investorshub | 06/29/2022 5:36:36 PM |
$AMPH buy 42.3299 | stocktrademan | investorshub | 04/17/2022 8:52:53 AM |
$AMPH 50/200sma crossed here...Nice bullish sign. | Golden Cross | investorshub | 06/24/2020 10:05:50 PM |
fda approval | atarabih | investorshub | 06/09/2020 10:22:00 AM |
Gearing up for another amazing surprise quarter of | MakeABuck2000 | investorshub | 01/12/2018 6:54:47 PM |
reading my friend, their drug helper going on | mick | investorshub | 11/10/2017 8:23:12 PM |
China has several generic-insulin products already on the market. | DewDiligence | investorshub | 03/18/2017 3:00:55 PM |
Do you see them investing in China to | Phaeton | investorshub | 03/18/2017 12:47:29 PM |
Squeezing up! I love it | Jess070283 | investorshub | 03/17/2017 4:46:36 PM |
Momenta, Sandoz allowed to broaden claims over quality | floblu14 | investorshub | 06/29/2016 4:40:25 PM |
AMPH is not a start-up, but it has | DewDiligence | investorshub | 05/13/2015 9:40:07 PM |
Update on Lovenox patent case: #msg-113632332. | DewDiligence | investorshub | 05/13/2015 9:38:27 PM |
No issue. | Phaeton | investorshub | 12/05/2014 3:52:30 AM |
IT IS 32 MILLION FROM NOW TO END | TREND1 | investorshub | 12/04/2014 5:47:09 PM |
They did give a number for their MANNKIND | Phaeton | investorshub | 12/04/2014 1:40:08 PM |
You just did not hear it .... | TREND1 | investorshub | 12/04/2014 2:42:24 AM |
They did not give any dollar figure for | Phaeton | investorshub | 12/04/2014 2:40:18 AM |
This EPS info is wrong. | TREND1 | investorshub | 12/04/2014 1:19:14 AM |
Phaeton Did you catch only 32 million sales to | TREND1 | investorshub | 12/04/2014 1:17:35 AM |
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
RANCHO CUCAMONGA, CA / ACCESSWIRE / January 8, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15 th , 2025, at 11:15 am PST...
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 26, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside chat at the 36th Annual Piper Sandler Healthcare Conference ...
Reports Net Revenues of $191.2 Million for the Three Months Ended September 30, 2024 RANCHO CUCAMONGA, CA / ACCESSWIRE / November 6, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended September 30, 2024. Thi...